Medical Equipments, Pharmaceuticals And Personal Care Products Tenders

Open House Discount Drug Contracts Lipegfilgrastim, Atc L03aa14

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the in Ii.2.4. Mentioned Active Ingredients with the Possibility of Conclusion Within the Framework of the So-Called Open-House Procedure.

Open House Drug Rebate Contracts Paliperidone in 1 Month Depot Dosage Forms, Atc N05ax13

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the in Ii.2.4. Mentioned Active Ingredients with the Possibility of Conclusion Within the Framework of the So-Called Open-House Procedure.

Conclusion of a Non-Exclusive Discount Agreement According to Section 130A Paragraph 8 Sgb V for Medicinal Products with the Active Ingredient Fondaparinux (Atc Code: B01ax05).

Conclusion of Non-Exclusive Discount Agreements in Accordance with §§ 130A Paragraph 8/130C Paragraph 1 Sgb V for Drugs with the Active Ingredient Guselkumab (L04ac16) as Part of a So-Called Open House Model.

Conclusion of Non-Exclusive Discount Agreements According to §§ 130A Abs. 8/130C Abs. 1 Sgb V for Drugs with the Active Ingredient Fluorouracil, Combinations (D11af55) as Part of an Open House Model.

Conclusion of Non-Exclusive Discount Agreements in Accordance with §§ 130A Paragraph 8/130C Paragraph 1 Sgb V for Drugs with the Active Ingredient Levothyroxine Sodium (H03aa01) as Part of a So-Called Open House Model.

Drug Discount Contracts with Option to Join - 0047-Rvbeitr.58-2022

Drug Discount Contracts According to § 130A Paragraph 8 Sgb V in the Context of Open House Procedures